Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 73 | 2025 | 588 | 14.750 |
Why?
|
| Arthroplasty, Replacement, Hip | 48 | 2023 | 759 | 9.820 |
Why?
|
| Knee Prosthesis | 28 | 2023 | 216 | 8.250 |
Why?
|
| Knee Joint | 42 | 2025 | 573 | 6.670 |
Why?
|
| Hip Prosthesis | 26 | 2023 | 515 | 6.000 |
Why?
|
| Femur | 20 | 2020 | 305 | 4.630 |
Why?
|
| Surgery, Computer-Assisted | 16 | 2017 | 51 | 4.300 |
Why?
|
| Prosthesis Failure | 24 | 2023 | 484 | 3.460 |
Why?
|
| Osteoarthritis, Knee | 20 | 2025 | 295 | 3.350 |
Why?
|
| Hip Joint | 17 | 2017 | 255 | 3.270 |
Why?
|
| Prosthesis Design | 28 | 2023 | 449 | 3.140 |
Why?
|
| Tibia | 17 | 2019 | 204 | 2.980 |
Why?
|
| Middle Aged | 80 | 2025 | 8072 | 2.880 |
Why?
|
| Retrospective Studies | 55 | 2022 | 3040 | 2.660 |
Why?
|
| Aged | 70 | 2025 | 7562 | 2.580 |
Why?
|
| Reoperation | 25 | 2023 | 776 | 2.550 |
Why?
|
| Humans | 123 | 2025 | 23355 | 2.550 |
Why?
|
| Bone Cements | 7 | 2023 | 82 | 2.430 |
Why?
|
| Female | 82 | 2025 | 13149 | 2.280 |
Why?
|
| Male | 81 | 2025 | 12655 | 2.270 |
Why?
|
| Postoperative Period | 22 | 2020 | 243 | 2.160 |
Why?
|
| Pain, Postoperative | 11 | 2020 | 273 | 1.940 |
Why?
|
| Postoperative Complications | 15 | 2022 | 836 | 1.860 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 593 | 1.710 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 258 | 1.690 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 90 | 1.660 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 48 | 1.590 |
Why?
|
| Treatment Outcome | 31 | 2023 | 2989 | 1.590 |
Why?
|
| Prospective Studies | 21 | 2020 | 1524 | 1.590 |
Why?
|
| Acetabulum | 6 | 2016 | 172 | 1.540 |
Why?
|
| Adult | 38 | 2019 | 7078 | 1.520 |
Why?
|
| Bone Malalignment | 7 | 2014 | 15 | 1.440 |
Why?
|
| Anticoagulants | 4 | 2015 | 85 | 1.390 |
Why?
|
| Venous Thromboembolism | 3 | 2015 | 35 | 1.340 |
Why?
|
| Joint Diseases | 4 | 2016 | 89 | 1.330 |
Why?
|
| Range of Motion, Articular | 15 | 2017 | 571 | 1.300 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 880 | 1.280 |
Why?
|
| Radiography | 19 | 2017 | 536 | 1.260 |
Why?
|
| Recovery of Function | 11 | 2016 | 246 | 1.180 |
Why?
|
| Noise | 3 | 2017 | 24 | 1.140 |
Why?
|
| Warfarin | 4 | 2015 | 25 | 1.120 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2016 | 158 | 1.100 |
Why?
|
| Bone Density | 3 | 2018 | 137 | 1.090 |
Why?
|
| Chromium | 3 | 2016 | 85 | 1.040 |
Why?
|
| Metals | 4 | 2017 | 135 | 1.020 |
Why?
|
| Cobalt | 3 | 2016 | 106 | 1.020 |
Why?
|
| Prosthesis-Related Infections | 5 | 2020 | 179 | 1.010 |
Why?
|
| Aspirin | 3 | 2015 | 48 | 0.990 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 26 | 0.970 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 42 | 0.880 |
Why?
|
| Osteolysis | 2 | 2017 | 131 | 0.870 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 3785 | 0.870 |
Why?
|
| Titanium | 4 | 2020 | 167 | 0.830 |
Why?
|
| Arthritis | 4 | 2020 | 46 | 0.810 |
Why?
|
| Biomechanical Phenomena | 11 | 2017 | 545 | 0.800 |
Why?
|
| Hip Dislocation | 6 | 2023 | 48 | 0.790 |
Why?
|
| Synovial Fluid | 2 | 2020 | 89 | 0.770 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.770 |
Why?
|
| Age Factors | 9 | 2018 | 641 | 0.750 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2021 | 4 | 0.740 |
Why?
|
| Arthroplasty, Replacement | 4 | 2013 | 132 | 0.740 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1039 | 0.740 |
Why?
|
| Accelerometry | 2 | 2012 | 78 | 0.710 |
Why?
|
| Surgical Wound | 2 | 2018 | 9 | 0.710 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 79 | 0.690 |
Why?
|
| Registries | 2 | 2018 | 176 | 0.660 |
Why?
|
| Pain Measurement | 4 | 2016 | 418 | 0.660 |
Why?
|
| Specimen Handling | 1 | 2020 | 40 | 0.650 |
Why?
|
| Lower Extremity | 3 | 2015 | 33 | 0.640 |
Why?
|
| Periprosthetic Fractures | 1 | 2020 | 26 | 0.630 |
Why?
|
| Incidence | 9 | 2018 | 636 | 0.620 |
Why?
|
| Joint Dislocations | 3 | 2023 | 50 | 0.600 |
Why?
|
| Equipment Failure Analysis | 4 | 2014 | 93 | 0.600 |
Why?
|
| Computer-Aided Design | 2 | 2016 | 11 | 0.600 |
Why?
|
| Research Design | 3 | 2015 | 157 | 0.570 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 7 | 0.570 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 813 | 0.560 |
Why?
|
| Risk Factors | 9 | 2022 | 1998 | 0.560 |
Why?
|
| Acceleration | 3 | 2012 | 20 | 0.560 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 311 | 0.560 |
Why?
|
| Ankle Joint | 5 | 2016 | 38 | 0.540 |
Why?
|
| Cadaver | 4 | 2012 | 286 | 0.540 |
Why?
|
| Risk Assessment | 3 | 2018 | 565 | 0.540 |
Why?
|
| Weight-Bearing | 2 | 2014 | 138 | 0.530 |
Why?
|
| Genu Varum | 1 | 2017 | 2 | 0.530 |
Why?
|
| Young Adult | 10 | 2019 | 1676 | 0.520 |
Why?
|
| Pelvic Bones | 1 | 2016 | 15 | 0.510 |
Why?
|
| Femur Neck | 1 | 2016 | 16 | 0.500 |
Why?
|
| Supine Position | 1 | 2016 | 16 | 0.490 |
Why?
|
| Prosthesis Fitting | 2 | 2013 | 19 | 0.490 |
Why?
|
| Analgesics, Opioid | 6 | 2020 | 210 | 0.490 |
Why?
|
| Patient Discharge | 3 | 2019 | 146 | 0.480 |
Why?
|
| Posture | 4 | 2017 | 56 | 0.480 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 230 | 0.470 |
Why?
|
| Hypersensitivity | 1 | 2016 | 46 | 0.470 |
Why?
|
| Joint Instability | 5 | 2025 | 313 | 0.460 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 18 | 0.440 |
Why?
|
| Osteoarthritis | 2 | 2016 | 279 | 0.440 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 594 | 0.420 |
Why?
|
| Patella | 1 | 2014 | 58 | 0.420 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 72 | 0.410 |
Why?
|
| Time Factors | 8 | 2019 | 1290 | 0.400 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 9 | 0.400 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 45 | 0.400 |
Why?
|
| Fibrosis | 1 | 2013 | 30 | 0.400 |
Why?
|
| Computer Simulation | 2 | 2016 | 175 | 0.390 |
Why?
|
| Missouri | 4 | 2016 | 25 | 0.390 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 15 | 0.380 |
Why?
|
| Gait | 3 | 2025 | 382 | 0.370 |
Why?
|
| Muscular Diseases | 1 | 2012 | 12 | 0.370 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 357 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 363 | 0.360 |
Why?
|
| United States | 8 | 2018 | 1829 | 0.360 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 268 | 0.350 |
Why?
|
| Blood Transfusion | 4 | 2022 | 58 | 0.350 |
Why?
|
| Pain | 4 | 2019 | 327 | 0.350 |
Why?
|
| Porosity | 2 | 2022 | 58 | 0.340 |
Why?
|
| Viscosity | 4 | 2019 | 10 | 0.340 |
Why?
|
| Rotation | 4 | 2014 | 110 | 0.340 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1441 | 0.340 |
Why?
|
| Adolescent | 6 | 2019 | 1917 | 0.340 |
Why?
|
| Osteoporosis | 1 | 2011 | 72 | 0.340 |
Why?
|
| Arthroscopy | 2 | 2014 | 555 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 430 | 0.320 |
Why?
|
| Rotator Cuff | 1 | 2012 | 213 | 0.320 |
Why?
|
| Joint Prosthesis | 4 | 2019 | 75 | 0.320 |
Why?
|
| Patient Positioning | 4 | 2017 | 34 | 0.310 |
Why?
|
| Body Mass Index | 4 | 2020 | 384 | 0.300 |
Why?
|
| Length of Stay | 5 | 2019 | 305 | 0.290 |
Why?
|
| Femur Head | 4 | 2023 | 45 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 251 | 0.280 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2018 | 12 | 0.280 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 129 | 0.270 |
Why?
|
| Corrosion | 3 | 2017 | 119 | 0.260 |
Why?
|
| Arthroplasty, Replacement, Elbow | 2 | 2019 | 6 | 0.260 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 79 | 0.260 |
Why?
|
| Polyethylene | 4 | 2019 | 116 | 0.260 |
Why?
|
| Osteocytes | 2 | 2019 | 18 | 0.260 |
Why?
|
| Blood Loss, Surgical | 2 | 2020 | 54 | 0.260 |
Why?
|
| Hip Fractures | 2 | 2018 | 24 | 0.250 |
Why?
|
| Sex Factors | 3 | 2017 | 391 | 0.250 |
Why?
|
| Patient Readmission | 3 | 2018 | 117 | 0.250 |
Why?
|
| Pain Management | 4 | 2020 | 126 | 0.250 |
Why?
|
| Cytokines | 2 | 2019 | 213 | 0.240 |
Why?
|
| Elbow Joint | 2 | 2019 | 114 | 0.240 |
Why?
|
| Hemorrhage | 2 | 2015 | 73 | 0.230 |
Why?
|
| Hand | 2 | 2018 | 39 | 0.230 |
Why?
|
| Awards and Prizes | 2 | 2016 | 21 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 1429 | 0.220 |
Why?
|
| Machine Learning | 1 | 2025 | 59 | 0.220 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 139 | 0.210 |
Why?
|
| Comorbidity | 2 | 2022 | 431 | 0.210 |
Why?
|
| Double-Blind Method | 2 | 2022 | 382 | 0.200 |
Why?
|
| Therapeutic Irrigation | 2 | 2020 | 46 | 0.200 |
Why?
|
| Urinary Retention | 1 | 2022 | 12 | 0.190 |
Why?
|
| Algorithms | 3 | 2019 | 314 | 0.190 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 16 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 31 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2022 | 55 | 0.190 |
Why?
|
| Vitamin D | 1 | 2022 | 28 | 0.190 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 57 | 0.180 |
Why?
|
| Equipment Design | 2 | 2012 | 124 | 0.180 |
Why?
|
| Postural Balance | 1 | 2022 | 100 | 0.180 |
Why?
|
| Cementation | 1 | 2021 | 32 | 0.180 |
Why?
|
| Orthopedics | 2 | 2013 | 88 | 0.170 |
Why?
|
| Surface Properties | 2 | 2019 | 125 | 0.170 |
Why?
|
| Refuse Disposal | 1 | 2020 | 2 | 0.170 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 16 | 0.170 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 17 | 0.160 |
Why?
|
| Leukocyte Count | 1 | 2020 | 61 | 0.160 |
Why?
|
| Arthroplasty | 2 | 2018 | 108 | 0.160 |
Why?
|
| Prescriptions | 1 | 2020 | 16 | 0.160 |
Why?
|
| Acetaminophen | 1 | 2020 | 22 | 0.160 |
Why?
|
| Los Angeles | 2 | 2017 | 10 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2019 | 22 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 66 | 0.160 |
Why?
|
| Neutrophils | 1 | 2020 | 94 | 0.160 |
Why?
|
| Wound Healing | 2 | 2018 | 114 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 169 | 0.160 |
Why?
|
| Pain Perception | 1 | 2019 | 5 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 124 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2019 | 125 | 0.150 |
Why?
|
| Pelvis | 2 | 2016 | 23 | 0.150 |
Why?
|
| Survivorship | 1 | 2019 | 13 | 0.150 |
Why?
|
| Oxycodone | 1 | 2019 | 4 | 0.150 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 18 | 0.150 |
Why?
|
| Mobile Applications | 1 | 2019 | 28 | 0.150 |
Why?
|
| Apoptosis | 1 | 2019 | 198 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 59 | 0.150 |
Why?
|
| alpha-Defensins | 1 | 2018 | 3 | 0.140 |
Why?
|
| Logistic Models | 2 | 2016 | 358 | 0.140 |
Why?
|
| Ceramics | 2 | 2015 | 19 | 0.140 |
Why?
|
| Morphine | 1 | 2019 | 70 | 0.140 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 7 | 0.140 |
Why?
|
| Surgeons | 2 | 2019 | 79 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2018 | 314 | 0.140 |
Why?
|
| Bone Remodeling | 1 | 2018 | 49 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 98 | 0.140 |
Why?
|
| Drainage | 1 | 2018 | 41 | 0.140 |
Why?
|
| Preoperative Period | 2 | 2020 | 64 | 0.140 |
Why?
|
| Arthritis, Infectious | 1 | 2018 | 48 | 0.140 |
Why?
|
| Knee | 1 | 2017 | 38 | 0.130 |
Why?
|
| Spine | 1 | 2018 | 97 | 0.130 |
Why?
|
| Motion | 1 | 2016 | 20 | 0.130 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.130 |
Why?
|
| Fascia Lata | 1 | 2016 | 6 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 21 | 0.130 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 30 | 0.130 |
Why?
|
| Ions | 1 | 2016 | 53 | 0.130 |
Why?
|
| Thigh | 1 | 2016 | 26 | 0.130 |
Why?
|
| Rats | 2 | 2019 | 628 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2016 | 31 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 62 | 0.120 |
Why?
|
| Midwestern United States | 1 | 2016 | 47 | 0.120 |
Why?
|
| Stockings, Compression | 1 | 2015 | 2 | 0.120 |
Why?
|
| Internal Fixators | 1 | 2016 | 34 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 289 | 0.120 |
Why?
|
| Preoperative Care | 2 | 2014 | 112 | 0.120 |
Why?
|
| Tennessee | 1 | 2015 | 6 | 0.120 |
Why?
|
| Great Lakes Region | 1 | 2015 | 1 | 0.120 |
Why?
|
| Joint Capsule | 2 | 2012 | 37 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 19 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 521 | 0.120 |
Why?
|
| Shoulder Joint | 2 | 2012 | 513 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 57 | 0.110 |
Why?
|
| Alloys | 1 | 2015 | 92 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2014 | 3 | 0.110 |
Why?
|
| Patients | 1 | 2015 | 31 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2014 | 10 | 0.110 |
Why?
|
| Software | 1 | 2014 | 50 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 218 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 68 | 0.110 |
Why?
|
| Knee Dislocation | 1 | 2014 | 2 | 0.110 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 7 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 323 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2014 | 48 | 0.110 |
Why?
|
| Femoral Nerve | 1 | 2014 | 9 | 0.110 |
Why?
|
| Amides | 1 | 2014 | 15 | 0.110 |
Why?
|
| Obesity | 1 | 2017 | 293 | 0.110 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2014 | 2 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 140 | 0.110 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 54 | 0.100 |
Why?
|
| Patellar Ligament | 1 | 2014 | 35 | 0.100 |
Why?
|
| Fluoroscopy | 1 | 2013 | 32 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 71 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 482 | 0.100 |
Why?
|
| Nerve Block | 1 | 2014 | 61 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2013 | 20 | 0.100 |
Why?
|
| Hip | 1 | 2013 | 28 | 0.100 |
Why?
|
| Pressure | 1 | 2013 | 51 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2025 | 41 | 0.100 |
Why?
|
| Leg | 1 | 2013 | 40 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 442 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 322 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 122 | 0.100 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 9 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 560 | 0.100 |
Why?
|
| Patient Selection | 1 | 2013 | 171 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2014 | 204 | 0.090 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 18 | 0.090 |
Why?
|
| Exercise | 1 | 2016 | 398 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 315 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2012 | 75 | 0.090 |
Why?
|
| Vasculitis | 1 | 2012 | 27 | 0.090 |
Why?
|
| Chromium Alloys | 1 | 2012 | 40 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2012 | 84 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2012 | 57 | 0.090 |
Why?
|
| Hemiarthroplasty | 1 | 2012 | 31 | 0.090 |
Why?
|
| Arthritis, Psoriatic | 1 | 2012 | 14 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 236 | 0.090 |
Why?
|
| Patellar Dislocation | 1 | 2012 | 21 | 0.090 |
Why?
|
| Computers, Handheld | 1 | 2011 | 13 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2011 | 23 | 0.090 |
Why?
|
| External Fixators | 1 | 2011 | 6 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 30 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 95 | 0.090 |
Why?
|
| Shoulder Injuries | 1 | 2012 | 113 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 203 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2011 | 58 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2012 | 126 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 104 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 774 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 262 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2013 | 404 | 0.080 |
Why?
|
| Animals | 2 | 2019 | 3301 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 109 | 0.080 |
Why?
|
| Rotator Cuff Injuries | 1 | 2012 | 226 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 39 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2011 | 205 | 0.070 |
Why?
|
| Risk | 2 | 2019 | 162 | 0.070 |
Why?
|
| Elective Surgical Procedures | 2 | 2019 | 35 | 0.070 |
Why?
|
| Early Ambulation | 2 | 2019 | 16 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2019 | 226 | 0.060 |
Why?
|
| Medicare | 2 | 2015 | 108 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 3 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 6 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 452 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 15 | 0.050 |
Why?
|
| Silver | 1 | 2021 | 3 | 0.040 |
Why?
|
| Bandages | 1 | 2021 | 4 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 153 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 88 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 45 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 88 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 5 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 74 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 88 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 79 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 58 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 339 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 285 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 129 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 220 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 78 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 116 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 356 | 0.030 |
Why?
|
| Colitis | 1 | 2017 | 25 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 168 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 26 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 68 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 127 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 58 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 487 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 26 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 24 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 36 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 34 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 326 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 5 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 155 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 4 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2014 | 6 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 116 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 85 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2015 | 61 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 10 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 10 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 79 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 157 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 270 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 82 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 83 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 192 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 154 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 104 | 0.020 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 5 | 0.020 |
Why?
|
| Fingers | 1 | 2012 | 8 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 272 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 72 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 177 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 166 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 84 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 306 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 73 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2009 | 35 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 114 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1171 | 0.020 |
Why?
|